Form 4: GoodRx Holdings Director Ian T Clark Reports Acquisition of Restricted Stock Units

Director Ian T Clark reports acquisition of 25,852 shares of Class A Common Stock and 51,745 Restricted Stock Units.

Summary

• Ian T Clark, a director of GoodRx Holdings, Inc., reported a transaction involving the acquisition of securities.
• On July 8, 2024, Clark acquired 25,852 shares of Class A Common Stock at $0 and 51,745 Restricted Stock Units.
• Following the transaction, Clark directly owns 25,852 shares of Class A Common Stock and 51,745 Restricted Stock Units.
• The restricted stock units vest in full on the earlier of June 6, 2025, or the date of the 2025 Annual Meeting of Stockholders, subject to continued service.
• Another restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on July 8, 2025, subject to continued service.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing indicating insider transactions. The acquisition of shares and RSUs can be seen as a positive sign, but it's not necessarily indicative of significant outperformance.

Positives

• The acquisition of shares and RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting schedules of the restricted stock units indicate a multi-year commitment from the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates